Mammalian orthoreovirus 1 (MRV‑1) is a non‑enveloped double‑stranded RNA virus belonging to the genus Orthoreovirus (family Reoviridae). It is one of three serotypes of mammalian orthoreoviruses that infect a broad range of mammals, including humans.
Structure, replication and host range
These viruses have a segmented genome of ten double‑stranded RNA segments (L1–L3, M1–M3, S1–S4) encoding structural and non‑structural proteins. The serotype is determined by the S1 segment that encodes the cell‑attachment σ1 protein. MRV‑1 strains are typified by the T1L prototype, originally isolated from a mouse brain in the 1950s. Replication occurs in the cytoplasm, where cores transcribe mRNA that is translated by host ribosomes; progeny cores are assembled in viral factories and acquire an outer capsid to form stable double‑layered particles. Human infection is acquired through fecal–oral or respiratory exposure. MRV‑1 replicates mainly in the gastrointestinal and respiratory epithelium; it can disseminate to lymphoid tissues and occasionally invade the central nervous system. In immunocompetent individuals infection is often asymptomatic or manifests as mild fever, rhinorrhea or diarrhea. Rarely, MRV‑1 has been linked to meningitis or pneumonia. Its non‑enveloped capsid confers resistance to environmental conditions and facilitates survival in water and on surfaces. There are no vaccines or specific antiviral drugs; management is supportive.
Research use and notable detections
Human orthoreoviruses were first isolated in 1953 from children with mild respiratory illness, giving rise to the term “respiratory enteric orphan” virus. The T1L strain has become a model for studying cell entry, uncoating and the role of segmented genomes in reassortment. In 2011 an MRV‑1 strain caused a cluster of aseptic meningitis cases in the United States, illustrating its capacity for neuroinvasion. Another variant dubbed “Nebraska virus” was identified in wastewater and shown to replicate at 37°C, underscoring adaptation to mammalian hosts. Serological studies reveal high rates of orthoreovirus antibodies in adults worldwide, indicating frequent exposure. Beyond natural infection, orthoreoviruses have been explored as oncolytic agents because they preferentially replicate in Ras‑activated tumour cells; the therapeutic pelareorep derives from a related serotype but highlights the broader biomedical interest in this genus. Mammalian orthoreovirus 1 circulates widely among mammals and humans, usually causing subclinical or mild disease. Its segmented genome and environmental stability make it an informative model for understanding reovirus biology and for developing novel therapeutic strategies. Related Terms: Mammalian Orthoreovirus 2, Mammalian Orthoreovirus 3, Avian orthoreovirus, Rotavirus, Pelareorep